AIForbes Innovationabout 2 hours ago
Insilico Medicine's AI Drug Discovery Breakthrough
1 min read
Insilico Medicine used generative AI to design a pulmonary fibrosis drug candidate that reached Phase 2 trials in under 18 months, a first for AI-designed drugs. Its Pharma.AI platform, including Chemistry42 and PandaClaw, is now licensed to 13 top pharmaceutical companies.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
